Search
Immunoprecise Antibodies Ltd
IPAAdd to Watchlist
2.070USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
95.54MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
2
analysts
Buy
Current Rating
4.000
Target Price
+107.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Immunoprecise Antibodies Ltd
IPA
2
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
Eli Lilly and Co
LLY
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Immunoprecise Antibodies Ltd's expected revenue for the next quarter?
Immunoprecise Antibodies Ltd's expected revenue is 3.15M.
How have Immunoprecise Antibodies LtdIPA's recent earnings per share performed?
The market expectation was USD -0.05, while Immunoprecise Antibodies LtdIPA's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.04.
What is the analyst rating for Immunoprecise Antibodies Ltd?
Based on the ratings of Immunoprecise Antibodies Ltd's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.